Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
279 Leser
Artikel bewerten:
(1)

ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers

The Center Certification Ceremony took place during the ICPO Reception on the occasion of the EANM conference on Oct 4, 2025, in Barcelona.

October 9, 2025 - Wiesbaden, Germany. The International Centers for Precision Oncology (ICPO) Foundation announced the cooperation with 24 additional Theranostics centers worldwide officially certifying them as ICPO Theranostics Clinical Centers of Excellence. With this expansion, the ICPO Center Network now comprises 45 Theranostics clinics, primarily located in Low- and Middle-Income Countries (LMICs). The foundation's aim is to strengthen these Theranostics centers by enhancing their clinical standards. ICPO is sharing knowledge, best practices, and education in Theranostics with its Center network to scale patient access to Theranostics and improve patient outcomes. To welcome the new ICPO Centers the 2nd ICPO Center Certification Ceremony took place during the ICPO Reception with about 90 stakeholders from the ICPO Theranostics Community, on Oct 4, 2025, right before the 2025 annual conference of the European Association of Nuclear Medicine (EANM) in Barcelona.

The ICPO Foundation is looking forward to cooperating with the new international state-of-the-art theranostics centers in seven geographical regions of the world: three centers in Africa, six centers in Latin America, four centers in India, four centers in Germany, as well as one center each in China, Turkey, Dubai, Australia, and Canada. All ICPO Theranostics Clinical Centers will promote the ICPO Academy for Theranostics and the ICPO center accreditation scheme in their respective countries, while also fostering research and development in the field of Theranostics. The ICPO Foundation will provide each center with support and international visibility within the ICPO Theranostics Community.

Odile Jaume, CEO, and Oliver Buck, Trustee of the ICPO Foundation, were honored to welcome over 90 guests including the new leaders of the ICPO Centers and their team members as well as academic experts, industry leaders and supporters, non-profit organizations and patient associations and patients to the ICPO Reception & Center Certification Ceremony in Barcelona on the occasion of the 2025 annual conference of the European Association of Nuclear Medicine (EANM).

Prof. Richard P. Baum, Trustee and President of the ICPO Academy for Theranostics, and Dr. Marwa Hakkam, Accreditation & Center Project Director, had the pleasure of handing over the certificates to the leaders of 24 new ICPO Theranostics Clinical Centers of Excellence, who attended the event in person in Barcelona.

In her welcome words, Odile Jaume, CEO, expressed her enthusiasm about all new centers and partners of the ICPO Foundation: "I am very proud of all milestones we have reached since the last EANM conference 2024 in Hamburg. With 45 ICPO Theranostics Clinical Centers of Excellence today, we are on track to extend our network to 100 in 2026. To enhance the impact of our mission, partnering is crucial. Therefore, we co-founded the RLT Angels Association, together with EANM, GE Healthcare, Novartis, and RayzeBio, a Bristol Myers Squibb company, - creating a cross-stakeholders powerhouse to advance the field of Theranostics with large scale targets and strong collective advocacy for better patient outcomes. Moreover, I am also energized by our new cooperations with the Oncidium Foundation, the Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB), and the Brazilian Society of Nuclear Medicine (SBMN), as well as with the Technical University Munich (TUM), all of these strongly contribute to scaling patient access to Theranostics for improved cancer patient care."

To further intensify the exchange with the global Theranostics community and present the accreditation process to new ICPO Clinical Centers of Excellence candidates and the latest development of its Academy for Theranostics, the ICPO Foundation participated in the upcoming EANM conference, which took place from October 4 to 8, 2025, in Barcelona.

List of new 24 ICPO Theranostics Clinical Centers of Excellence:

  1. Universitas Academic Hospital, Bloemfontein, South Africa, Dr. Tebatso Tabeila
  2. University College Hospital, Ibadan, Idadan, Nigeria, Dr. Kolade Olumayowa
  3. Kenyatta University Teaching Referral, and Research Hospital, Nairobi, Kenya, Dr. Harsih Nagaraj
  4. Centro de Medicina Nuclear Clinica Modelo UTHERSA, Uthersa, Argentina, Dr. Mariela Agolti
  5. Fundacion Escuela Medicina Nuclear FUESMEN Mendoza, Argentina, Dr. Sergio Mosconi
  6. Hospital Ángeles Pedregal, Mexico City, Mexico, Dr. Jorge Schalch
  7. Oncologia San Jose, Sonora, Mexico, Dr. Danny Mena Cortes
  8. Fundación Santa Fe de Bogotá, Bogota, Colombia, Dr. Julian Rojas Camacho
  9. National Cancer Institute (INC), Bogota, Colombia, Dr. Marylin Acuña Hernandez
  10. University Hospital Augsburg, Augsburg, Germany, Dr. Constantin Lapa
  11. University Hospital Magdeburg, Magdeburg, Germany, Dr. Michael Kreissl
  12. Curanosticum, Wiesbaden, Germany, Dr. Richard P. Baum
  13. University Hospital Essen, Essen, Germany, Dr. Ken Herrmann
  14. Artemis Hospital, Gurugram, India, Dr. Noaline Sinha
  15. Max Healthcare Institute, Delhi, India, Dr. Jaspriya Bal
  16. Sanjay Gandhi Institute of Medical Sciences, Lucknow, India, Dr. Aftab Hasan Nazar
  17. Rohtak Nuclear Medcare LLP (RNM), Rohtak, India, Dr. Parveen Kundu
  18. Sarvodaya Hospital and Research Centre, Faridabad, India, Dr. Swagat Dash
  19. Neumod- Nuclear Medicine and Molecular Theranostics, Hubli, India, Dr. Rashmi Angadi
  20. Bilkent City Hospital, Ankara, Turkey, Dr. Nazim Coskun
  21. Dubai Nuclear Medicine & Molecular Imaging, Dubai, United Arab Emirates, Dr. Batool Albalooshi
  22. Beijing Cancer Hospital, Beijing, China, Dr. Li Ziyu
  23. Austin Health, Melbourne, Australia, Dr. Andrew Scott
  24. INITIO Medical, Burnaby, Canada, Mina Bechai and Dr. Philip Cohen

Photo caption: ICPO Center Certification Ceremony with 24 new ICPO Theranostics Clinical Center of Excellence in Barcelona on the occasion of the 2025 EANM conference.

About ICPO Foundation

The International Centers for Precision Oncology Foundation

Learn more about the ICPO Foundation at www.icpo.foundation and the ICPO Academy for Theranostics at www.theranostics.academy

Media contact ICPO Foundation
Susanne Simon, Head of Communication & Community
Email: susanne.simon@icpo.foundation, Phone: + 49 172 8666093, www.icpo.foundation

Attachments

  • ICPO Center Certification Ceremony with 24 new ICPO Theranostics Clinical Center of Excellence in Barcelona on the occasion of the 2025 EANM conference (https://ml-eu.globenewswire.com/Resource/Download/c8634fd3-c896-49ab-b026-91977c58377e)
  • 2025_10_09_PR 23 New ICPO Centers Oct 2025. eng_Final (https://ml-eu.globenewswire.com/Resource/Download/4e03eb34-3b70-4b31-ab1d-59a6bfbac78d)

© 2025 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.